LanzaTech Global, Inc. (LNZA) Q3 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals significant financial challenges, including a decline in revenue and increased operating expenses. Despite some positive developments like increased ownership in LanzaJet and a $40 million investment, there are major concerns such as timing uncertainties, cash flow risks, and regulatory adoption issues. The Q&A section highlights vague responses from management, which could further unsettle investors. While there are optimistic elements, the overall sentiment is negative due to financial losses, cost control challenges, and project risks.
Key Financial Performance
Total Revenue Q3 2024 $9.9 million, down $7 million year-over-year; primarily due to the expected LanzaJet sublicense event not occurring and depressed ethanol pricing.
Biorefining Revenue Q3 2024 $5.9 million, down $6.5 million year-over-year; lower than Q3 2023 due to high engineering services revenue in the prior year.
Joint Development and Contract Research Revenue Q3 2024 $1.8 million, down $1 million from Q2 2024; primarily due to completion of government projects and downtime before new projects.
CarbonSmart Product Sales Revenue Q3 2024 $2.2 million, up from $0.9 million in Q2 2024; in line with Q3 2023, driven by increased direct fuel product sales despite lower ethanol prices.
Cost of Revenue Q3 2024 $8.1 million, down from $14.4 million in Q3 2023; related to headcount allocations and higher CarbonSmart sales.
Gross Margin Q3 2024 18% of revenue; impacted by revenue mix and absence of high-margin LanzaJet share issuance revenue.
Operating Expenses Q3 2024 $34.8 million, up $5 million year-over-year; flat compared to Q2 2024, driven by project development expenses.
Adjusted EBITDA Q3 2024 Loss of $27.1 million, compared to a loss of $19.1 million in Q3 2023; due to lower revenues and higher project development expenses.
Cash Position Q3 2024 $89.1 million, up from $75.8 million at the end of Q2 2024; increase attributed to a $40 million investment by Carbon Direct Capital.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
LanzaTech Nutritional Protein: Announced ability to produce single-cell protein, targeting the $1 trillion alternative protein market.
Ethanol Off-take Agreement: Signed a two-stage ethanol off-take agreement with ArcelorMittal, with potential annual revenue of $6 million to $20 million.
Project Drake: 30 million gallon per year ethanol to sustainable aviation fuel project, expected to positively impact Q4 financial performance.
Project SECURE: Progressing well, with potential revenue of approximately $4 million before year-end.
Joint Venture with Olayan Group: Expected to finance and cultivate commercial opportunities in the Middle East.
Cost Control: Focused on controlling and reducing costs, with operating expenses at $34.8 million, below budget.
Cash Position: Increased cash position to $89.1 million, attributed to a $40 million investment by Carbon Direct Capital.
Business Model Evolution: Evolving from a licensing model to developing and financing own projects for greater control and profitability.
Partnership Approach: Adopting a partnership approach with capital partners to secure financing for project development.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Revenue Shortfall: Third quarter revenue was $9.9 million, about $7 million below target due to the expected LanzaTech sublicense event not occurring and depressed ethanol pricing.
Market Dynamics: Ethanol pricing in the target market was significantly below expectations, impacting CarbonSmart revenue despite a quarter-over-quarter increase.
Project Development Risks: The company is evolving its business model to take more control over project development, which involves risks associated with securing capital and managing project timelines.
Timing Uncertainty: Several key initiatives, including Project Drake and the next LanzaJet sublicensing event, have timing uncertainties that could affect fourth quarter financial outcomes.
Cost Control Challenges: Operating expenses increased year-over-year, driven by project development costs, although the company is focused on controlling and reducing costs.
Cash Flow Risks: The company faces risks related to cash flow generation, particularly if anticipated revenues from projects do not materialize as expected.
Regulatory and Market Adoption Risks: The reliance on the adoption and decision cycles of licensees poses risks to the business model, potentially delaying revenue recognition.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Business Model Evolution: LanzaTech is evolving its business model to complement its licensing business and enhance its capability to develop and finance its own projects, allowing for greater control over timing and performance.
Project Drake: Project Drake is a 30 million gallon per year ethanol to sustainable aviation fuel project expected to reach final investment decision in 2025, with significant positive impact on financial performance.
Partnerships: LanzaTech is partnering with Brookfield Asset Management for project financing and with the Olayan Group for commercial opportunities in the Middle East.
Ethanol Off-take Agreement: A two-stage ethanol off-take agreement with ArcelorMittal is expected to generate $6 million in annual revenue short-term and $10 million to $20 million per year long-term.
Sustainable Aviation Fuel Projects: LanzaTech is involved in multiple sustainable aviation fuel projects globally, indicating strong market interest.
Single-Cell Protein Production: LanzaTech has developed the capability to produce single-cell protein, targeting the $1 trillion alternative protein market.
Q4 2024 Revenue Expectations: LanzaTech expects a range of revenue outcomes for Q4 2024, with potential drivers including $20 million from the Norway project, similar revenue from Project Drake, and $4 million from Project SECURE.
LanzaJet Sublicensing Agreements: Potential signing of additional LanzaJet sublicensing agreements could result in significant revenue recognition.
2025 Financial Outlook: LanzaTech anticipates that ongoing projects will unlock access to cash, significantly bolstering financial liquidity and accelerating the path to profitability.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Settlement Payment: A $10 million settlement payment was made to ACM to fully satisfy obligations under a forward purchase agreement, reducing the number of issued and outstanding common shares.
LanzaJet Sublicensing Agreements: Potential for receiving additional shares and revenue from LanzaJet sublicensing agreements, with expectations of significant revenue recognition associated with share consideration.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Is the $5 million from Project Drake going to hit in the fourth quarter? Is it included in the $10 million base revenue?
A:The $5 million is an exclusivity fee and is expected to be recognized as revenue in Q4. It is not part of the $10 million base revenue, which reflects ongoing business performance.
Q:Can you clarify the cost savings initiatives? Why have cash costs gone up?
A:Costs have increased due to expenses related to Project Drake and Project Exelixis as they are being developed. However, there have been reductions in other OpEx items.
Q:Can you provide more details on bringing in infrastructure partners for financing?
A:We are working with multiple infrastructure partners beyond Brookfield, including a completed JV with Olayan in the Middle East.
Q:What benefits does the emitter receive if they are not contributing capital to the project?
A:Emitters benefit by reducing their emissions and gaining access to low-carbon products.
Q:Will the financers retain a long-term interest in the project?
A:Financers may retain a long-term interest, but specifics depend on the agreements made.
Q:What is the expected free cash flow conversion from the Norwegian project?
A:The $20 million is indicative of catch-up costs and there will be future revenue expectations as we continue to provide services.
Q:What is the status of the SAF plant at Freedom Pines?
A:We have started FEED into the system, but we are not producing SAF yet.
Q:What are your thoughts on the impact of the upcoming election on your business?
A:The election removes uncertainty, and while it may impact U.S. projects, LanzaTech operates globally and is not solely reliant on U.S. policies.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the specific benefits to emitters not contributing capital, and the long-term interest of financers in projects was also vague.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ACM
Eramet
JV
Middle East
New Zealand
Project SECURE
access
amino acid
animal feed
bacteria
benefit
bioreactor
carbon intensity
case
certainty
contract
development service
election
emitter
ethanol SAF
ethanol price
ethylene
folk
food
infrastructure partner
isopropanol
nitrogen
platform
position
product carbon
product sale
project FID
project Norway
protein product
stage project
thing
volume
LNZA Transcript
LanzaTech Global, Inc. (LNZA) Q3 2024 Earnings Call Transcript
Unknown11-8
The earnings call reveals significant financial challenges, including a decline in revenue and increased operating expenses. Despite some positive developments like increased ownership in LanzaJet and a $40 million investment, there are major concerns such as timing uncertainties, cash flow risks, and regulatory adoption issues. The Q&A section highlights vague responses from management, which could further unsettle investors. While there are optimistic elements, the overall sentiment is negative due to financial losses, cost control challenges, and project risks.
LanzaTech Global, Inc. (LNZA) Q2 2024 Earnings Call Transcript
Positive8-11
The earnings call summary highlights strong financial performance with a 35% revenue growth and improved EBITDA loss. The partnership with Technip Energies and investment from Carbon Direct Capital are positive catalysts. The Q&A section indicates potential market expansion and sufficient liquidity. Despite some uncertainty in management responses, the overall sentiment is positive, supported by optimistic guidance and strategic partnerships.
LanzaTech Global, Inc. (LNZA) Q1 2024 Earnings Call Transcript
Neutral5-10
LanzaTech Global, Inc. (LNZA) Q4 2023 Earnings Call Transcript
Neutral2-28
LNZA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
